tiprankstipranks
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
US Market

Mangoceuticals, Inc. (MGRX) Stock Price & Analysis

31 Followers

MGRX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.14 - $3.18
Previous Close$0.24
Volume106.94K
Average Volume (3M)1.06M
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$1.24M
Total Debt (Recent Filing)$143.43K
Price to Earnings (P/E)-0.4
Beta-3.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.60
Shares Outstanding23,619,500
10 Day Avg. Volume283,571
30 Day Avg. Volume1,063,396
Standard Deviation0.35
R-Squared0.06
Alpha-0.11
Financial Highlights & Ratios
Price to Book (P/B)4.22
Price to Sales (P/S)40.80
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

36.20%0.03%0.22%63.55%
36.20% Insiders
0.22% Other Institutional Investors
63.55% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

MGRX FAQ

What was Mangoceuticals, Inc.’s price range in the past 12 months?
Mangoceuticals, Inc. lowest stock price was $0.14 and its highest was $3.18 in the past 12 months.
    What is Mangoceuticals, Inc.’s market cap?
    Currently, no data Available
    When is Mangoceuticals, Inc.’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Mangoceuticals, Inc.’s earnings last quarter?
    Currently, no data Available
    Is Mangoceuticals, Inc. overvalued?
    According to Wall Street analysts Mangoceuticals, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Mangoceuticals, Inc. pay dividends?
      Mangoceuticals, Inc. does not currently pay dividends.
      What is Mangoceuticals, Inc.’s EPS estimate?
      Mangoceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Mangoceuticals, Inc. have?
      Mangoceuticals, Inc. has 23,619,500 shares outstanding.
        What happened to Mangoceuticals, Inc.’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Mangoceuticals, Inc.?
        Currently, no hedge funds are holding shares in MGRX
        ---

        Mangoceuticals, Inc. Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Negative
        20 days / 200 days
        Momentum
        -76.31%
        12-Months-Change

        Fundamentals

        Return on Equity
        -1326.69%
        Trailing 12-Months
        Asset Growth
        4.74%
        Trailing 12-Months

        Company Description

        Mangoceuticals, Inc.

        Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provide access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED product.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Amicus
        Alnylam Pharma
        PTC Therapeutics
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis